This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Elaine Shapiro, PhD; Arthur K. Shapiro, MD; George Fulop, MD; Michael Hubbard, PhD; John Mandeli, PhD; Johanna Nordlie, MA; Robert A. Phillips, MD, PhD

Arch Gen Psychiatry. 1989;46(8):722-730.

Abstract
• The results of this controlled study of the treatment of 57 patients with Gilles de la Tourette's syndrome suggested that both haloperidol and pimozide were more effective than placebo, but that haloperidol was slightly more effective than pimozide. Adverse effects occurred more frequently with haloperidol vs placebo than with pimozide vs placebo, but the frequency was not significantly different for haloperidol compared with pimozide. Clinically significant cardiac effects did not occur at a maximum dosage of 0.3 mg/kg or 20 mg/d for pimozide and 10 mg/d for haloperidol. However, the QTc interval was prolonged during pimozide treatment compared with that during haloperidol treatment, although the values for both medications were not in an abnormal range.

Author Affiliations
From the Tourette and Tic Laboratory and Clinic, New York (Drs E. Shapiro and A. Shapiro); and the Departments of Psychiatry (Drs E. Shapiro, A. Shapiro, and Fulop and Ms Nordlie), Biomathematical Sciences (Drs Hubbard and Mandeli), and Medicine (Dr Phillips), Mount Sinai School of Medicine, New York.

Footnotes
Accepted for publication May 16, 1988.

Reprint requests to Tourette and Tic Laboratory and Clinic, 35 E 85th St, New York, NY 10028 (Dr A. Shapiro).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom
Rani et al.
Pediatrics 2008;121:1002-1009.
ABSTRACT | FULL TEXT  

Brief Review of Habit Reversal Training for Tourette Syndrome
Himle et al.
J Child Neurol 2006;21:719-725.
ABSTRACT  

Habit Reversal Training for Tic Disorders in Children and Adolescents
Piacentini and Chang
Behav Modif 2005;29:803-822.
ABSTRACT  

Assessment of Scientific and Ethical Issues in Two Randomized Clinical Trial Designs for Patients With Tourette's Syndrome: A Model for Studies of Multiple Neuropsychiatric Diagnoses
Gilbert and Buncher
J. Neuropsychiatry Clin. Neurosi. 2005;17:324-332.
ABSTRACT | FULL TEXT  

Ropinirole in Gilles de la Tourette syndrome
Anca et al.
Neurology 2004;62:1626-1627.
ABSTRACT | FULL TEXT  

The Tourette's Disorder Scale (TODS): Development, Reliability, and Validity
Shytle et al.
Assessment 2003;10:273-287.
ABSTRACT  

A placebo-controlled trial of risperidone in Tourette syndrome
Scahill et al.
Neurology 2003;60:1130-1135.
ABSTRACT | FULL TEXT  

Basal Ganglia Volumes in Patients With Gilles de la Tourette Syndrome
Peterson et al.
Arch Gen Psychiatry 2003;60:415-424.
ABSTRACT | FULL TEXT  

Tic reduction with pergolide in a randomized controlled trial in children
Gilbert et al.
Neurology 2003;60:606-611.
ABSTRACT | FULL TEXT  

A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder
Niederhofer et al.
J Psychopharmacol 2003;17:113-119.
ABSTRACT  

A Double-blind Comparison of Desipramine and Placebo in Children and Adolescents With Chronic Tic Disorder and Comorbid Attention-Deficit/Hyperactivity Disorder
Spencer et al.
Arch Gen Psychiatry 2002;59:649-656.
ABSTRACT | FULL TEXT  

A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder
Scahill et al.
Am. J. Psychiatry 2001;158:1067-1074.
ABSTRACT | FULL TEXT  

Baclofen treatment in Tourette syndrome: A double-blind, placebo-controlled, crossover trial
Singer et al.
Neurology 2001;56:599-604.
ABSTRACT | FULL TEXT  

Treatment interventions and findings from research: bridging the chasm in child psychiatry
GRAHAM
Br. J. Psychiatry 2000;176:414-419.
ABSTRACT | FULL TEXT  

Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial
Gilbert et al.
Neurology 2000;54:1310-1315.
ABSTRACT | FULL TEXT  

Tourette syndrome, associated conditions and the complexities of treatment
Robertson
Brain 2000;123:425-462.
ABSTRACT | FULL TEXT  

Psychopharmacology: Novel Antipsychotic Medications in the Treatment of Children and Adolescents
Malone et al.
Psychiatr. Serv. 1999;50:171-174.
FULL TEXT  

Risperidone in the treatment of Tourette syndrome: a retrospective case note study
Robertson et al.
J Psychopharmacol 1996;10:317-320.
ABSTRACT  

Neurochemical and some related psychopharmacological aspects of Tourette's syndrome: an update
Baker et al.
J Psychopharmacol 1995;9:273-280.
ABSTRACT  

Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder: A Double-blind, Placebo-Controlled Study in Patients With and Without Tics
McDougle et al.
Arch Gen Psychiatry 1994;51:302-308.
ABSTRACT  

Effective treatment of Tourette's syndrome with marijuana
Hemming and Yellowlees
J Psychopharmacol 1993;7:389-391.
ABSTRACT  

Clonidine Treatment of Gilles de la Tourette's Syndrome
Leckman et al.
Arch Gen Psychiatry 1991;48:324-328.
ABSTRACT  

Gilles de la Tourette Syndrome Is Not Linked to D2-Dopamine Receptor
Gelernter et al.
Arch Gen Psychiatry 1990;47:1073-1077.
ABSTRACT